# Reversal of Atrial Substrate to Prevent Atrial

> **NCT03682991** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Nova Scotia Health Authority** · enrollment: 509 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **OTHER:** Aggressive Risk Factor Control
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT03682991
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-01
- **Primary completion:** 2027-09-15
- **Final completion:** 2027-12-31
- **Target enrollment:** 509 (ACTUAL)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03682991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03682991, "Reversal of Atrial Substrate to Prevent Atrial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03682991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*